Abstract
6-Mercaptopurine (6MP), an analogue of the purine base hypoxanthine, is commonly used in the maintenance therapy of acute lymphoblastic leukemia (ALL) in children1.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
L. Lennard, J.S. Lilleyman, Variable mercaptopurine metabolism and treatment outcome in childhood lymphoblasic leukemia, J. Clin. Oncol. 7:1816 (1989).
L. Lennard, D. Keen, J.S. Lilleyman, Oral 6-mercaptopurine in childhood leukemia: parent drug pharmacokinetics and active metabolite concentrations, Clin. Pharmacol. Ther. 40:287 (1986).
M. Uchida, T. Nakamura, H. Uchino, Conversion of 6-mercaptopurine to 6-thioguanylic acid in L1210 cells and human leukemia cells, Jpn.J. Cancer Res. (GANN) 76:124 (1985).
J.P.M. Bökkerink, F.J. Damen, T.W. Hulscher, M.A.H. Bakker, J. A van Baal, R.A. De Abreu, 6-mercaptopurine cytotoxicity and biochemical pharmacology in human malignant lymphoblasts of different lineages, submitted
J.A. Nelson, J.W. Carpenter, L.M. Rose, D.J. Adamson, Mechanisms of action of 6-thioguanine, 6-mercaptopurine and 8-azaguanine, Cancer Res. 35:2872 (1975).
J. Maybaum, H.G. Mandel, Unilateral chromatid damage: a new basis for 6-thioguanine cytotoxicity, Cancer Res. 43:3852 (1983).
N.T. Cristie, S. Drake, R.E. Meyn, J.A Nelson, 6-Thioguanine-induced DNA-damage as determinant of cytotoxicity in cultured hamster ovary cells, Cancer Res. 44:3665 (1984).
F.R. Collart, E. Huberman, Expression of IMP dehydrogenase in differentiating HL60 cells, Blood 75:570 (1990).
L.L. Bennet, P.W. Allan, Formation and significance of 6-methylthiopurine ribonucleotide as a metabolite of 6-mercaptopurine, Cancer Res. 31:152 (1971).
C.N. Remy, Metabolism of thiopyrimidines and thiopurines; S-methylation with S-adenosyl methionine transmethylase and catabolism in mammalian tissue, J. Biol. Chem. 238:1078 (1963).
A R.P. Paterson, D.M. Tidd, 6-thiopurines, in: “Antineoplastic and immunosuppressive agents II”, A.C. Sartorelli, ed, Plenum Berlin, Heidelberg, New York (1975).
R.A. De Abreu, J.M. van Baal, J.AJ.M. Bakkeren, C.H.M.M. de Bruyn, E.D.A.M. Schretlen, High performance liquid Chromatographic assay for identification and quantitation of nucleotides in lymphocytes and malignant lymphoblasts, J. Chromatogr. 227:45 (1982).
J.P.M. Bökkerink, M.A.H. Bakker, T.W. Hulscher, R.A De Abreu, E.D.A M. Schretlen, Purine de novo synthesis as the basis of synergism of methotrexate and 6-mercaptopurine in human malignant lymphoblasts of different lineages, Biochem. Pharmacol. 37:2321 (1988).
H.J. Lee, K. Pawlak, B.T. Nguyen, R.K. Robbins, W. Sadée, Biochemical differences among four inosinate dehydrogenase inhibitors, mycophenolic acid, ribavirin, tiazofurin, and selenazofurin, studied in mouse lymphoma cell culture, Cancer Res. 45:5512 (1985).
S.M. Kharbanda, M.L. Sherman, D.W. Kufe, Effects of tiazofurin on guanine nucleotide binding regulatory proteins in HL60 cells, Blood 75:583 (1990).
M.T. Rizzo, G.T. Tricot, R. Hoffman, H.N. Nayaram, G. Weber, J.G.N. Garcia, D. English, IMPDH inhibitors. Probes for investigation of the functions of guanine binding proteis in intact cells, Cell. Signal. 2:509 (1990).
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1991 Springer Science+Business Media New York
About this chapter
Cite this chapter
Stet, E.H., De Abreu, R.A., Janssen, Y.P.G., Bökkerink, J.P.M., Trijbels, J.M.F. (1991). 6-Mercaptopurine Metabolism in Two Leukemic Cell Lines. In: Harkness, R.A., Elion, G.B., Zöllner, N. (eds) Purine and Pyrimidine Metabolism in Man VII. Advances in Experimental Medicine and Biology, vol 309A. Springer, Boston, MA. https://doi.org/10.1007/978-1-4899-2638-8_18
Download citation
DOI: https://doi.org/10.1007/978-1-4899-2638-8_18
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4899-2640-1
Online ISBN: 978-1-4899-2638-8
eBook Packages: Springer Book Archive